there was a 40 % reduction in the rate of otitis media among patients receiving sulfisoxazole compared with those receiving placebo ( 0.25 v 0.42 episode per patient-month ) which did not depend on age , sex , season , or several other factors .
C0029882
otitis media
C0038745
sulfisoxazole